A detailed history of Omni Star Financial Group, Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 34,978 shares of ORGO stock, worth $100,736. This represents 0.13% of its overall portfolio holdings.

Number of Shares
34,978
Previous 30,999 12.84%
Holding current value
$100,736
Previous $99,000 52.53%
% of portfolio
0.13%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$2.89 - $6.21 $11,499 - $24,709
3,979 Added 12.84%
34,978 $151,000
Q4 2024

Feb 14, 2025

BUY
$2.77 - $4.43 $85,867 - $137,325
30,999 New
30,999 $99,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $377M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Omni Star Financial Group, Inc. Portfolio

Follow Omni Star Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.